Search research articles
Contact Us
Filters
Showing results (261-270 of 285) with videos related to
Page
of 29
Sort By:
Biorxiv : the Preprint Server for Biology
|
March 27, 2026
Estrogen receptor-positive cell line xenograft models recapitulate metastatic dissemination and endocrine response of invasive lobular breast carcinoma
Nilgun Tasdemir, Laura Savariau, Julie Scott, et al.
Science Translational Medicine
|
March 28, 2014
Epigenetic reprogramming of HOXC10 in endocrine-resistant breast cancer
Thushangi N Pathiraja, Shweta R Nayak, Yuanxin Xi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 27, 2015
Sensitive Detection of Mono- and Polyclonal ESR1 Mutations in Primary Tumors, Metastatic Lesions, and Cell-Free DNA of Breast Cancer Patients
Peilu Wang, Amir Bahreini, Rekha Gyanchandani, et al.
The Lancet. Oncology
|
December 17, 2009
Prognostic and predictive value of the 21-gene recurrence score assay in postmenopausal women with node-positive, oestrogen-receptor-positive breast cancer on chemotherapy: a retrospective analysis of a randomised trial
Kathy S Albain, William E Barlow, Steven Shak, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 2, 2016
Updating the American Society of Clinical Oncology Value Framework: Revisions and Reflections in Response to Comments Received
Lowell E Schnipper, Nancy E Davidson, Dana S Wollins, et al.
Cancer Prevention Research (Philadelphia, Pa.)
|
December 12, 2018
AACR White Paper: Shaping the Future of Cancer Prevention - A Roadmap for Advancing Science and Public Health
Scott M Lippman, Cory Abate-Shen, Karen L Colbert Maresso, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 24, 2015
American Society of Clinical Oncology Statement: A Conceptual Framework to Assess the Value of Cancer Treatment Options
Lowell E Schnipper, Nancy E Davidson, Dana S Wollins, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
December 6, 2014
TBCRC 008: early change in 18F-FDG uptake on PET predicts response to preoperative systemic therapy in human epidermal growth factor receptor 2-negative primary operable breast cancer
Roisin M Connolly, Jeffrey P Leal, Matthew P Goetz, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 19, 2007
Clinical cancer advances 2007: major research advances in cancer treatment, prevention, and screening--a report from the American Society of Clinical Oncology
Julie Gralow, Robert F Ozols, Dean F Bajorin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 20, 2011
C-MYC alterations and association with patient outcome in early-stage HER2-positive breast cancer from the north central cancer treatment group N9831 adjuvant trastuzumab trial
Edith A Perez, Robert B Jenkins, Amylou C Dueck, et al.
Page
of 29
Search research articles
Search
Showing results (261-270 of 285) with videos related to
Sort By:
Page
of 29
Biorxiv : the Preprint Server for Biology
|
March 27, 2026
Estrogen receptor-positive cell line xenograft models recapitulate metastatic dissemination and endocrine response of invasive lobular breast carcinoma
Nilgun Tasdemir, Laura Savariau, Julie Scott, et al.
Science Translational Medicine
|
March 28, 2014
Epigenetic reprogramming of HOXC10 in endocrine-resistant breast cancer
Thushangi N Pathiraja, Shweta R Nayak, Yuanxin Xi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 27, 2015
Sensitive Detection of Mono- and Polyclonal ESR1 Mutations in Primary Tumors, Metastatic Lesions, and Cell-Free DNA of Breast Cancer Patients
Peilu Wang, Amir Bahreini, Rekha Gyanchandani, et al.
The Lancet. Oncology
|
December 17, 2009
Prognostic and predictive value of the 21-gene recurrence score assay in postmenopausal women with node-positive, oestrogen-receptor-positive breast cancer on chemotherapy: a retrospective analysis of a randomised trial
Kathy S Albain, William E Barlow, Steven Shak, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 2, 2016
Updating the American Society of Clinical Oncology Value Framework: Revisions and Reflections in Response to Comments Received
Lowell E Schnipper, Nancy E Davidson, Dana S Wollins, et al.
Cancer Prevention Research (Philadelphia, Pa.)
|
December 12, 2018
AACR White Paper: Shaping the Future of Cancer Prevention - A Roadmap for Advancing Science and Public Health
Scott M Lippman, Cory Abate-Shen, Karen L Colbert Maresso, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 24, 2015
American Society of Clinical Oncology Statement: A Conceptual Framework to Assess the Value of Cancer Treatment Options
Lowell E Schnipper, Nancy E Davidson, Dana S Wollins, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
December 6, 2014
TBCRC 008: early change in 18F-FDG uptake on PET predicts response to preoperative systemic therapy in human epidermal growth factor receptor 2-negative primary operable breast cancer
Roisin M Connolly, Jeffrey P Leal, Matthew P Goetz, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 19, 2007
Clinical cancer advances 2007: major research advances in cancer treatment, prevention, and screening--a report from the American Society of Clinical Oncology
Julie Gralow, Robert F Ozols, Dean F Bajorin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 20, 2011
C-MYC alterations and association with patient outcome in early-stage HER2-positive breast cancer from the north central cancer treatment group N9831 adjuvant trastuzumab trial
Edith A Perez, Robert B Jenkins, Amylou C Dueck, et al.
Page
of 29